Bladder Cancer Advocacy Network retweeted
Always a pleasure chatting with Rick Bangs! Hard to believe this is my 5th appearance!
This time, we discuss a particularly timely topic: bladder preservation after systemic therapy for #MIBC. With the impressive responses we're seeing from newer regimens, the opportunities are exciting, but important questions remain about who can safely avoid cystectomy.
Thanks for having me back! #BladderCancer @BladderCancerUS @IBCG_BladderCA @MDAndersonnews @WorldBladderCan
bcan.org/podcast-keeping-you… #ESMO2026
Welcome to the 5-timers club! @UroDocAsh joins us for his 5th appearance on the podcast. Listen as he and Rick Bangs discuss bladder preservation after treatment for muscle-invasive bladder cancer.
Welcome to the 5-timers club! @UroDocAsh joins us for his 5th appearance on the podcast. Listen as he and Rick Bangs discuss bladder preservation after treatment for muscle-invasive bladder cancer.
Join BCAN Bladder Cancer Matters podcast host Rick Bangs and Dr. David McConkey of @UR_Med on Oct. 22 at noon ET for a webinar on bladder cancer in New York State, treatment advances and patient resources.
Register here: rochester.zoom.us/webinar/re…
Bladder Cancer Advocacy Network retweeted
What does “response” really mean to patients with #BladderCancer?
Is it CR? Cure? Or maintaining a great QoL with cancer, even without a CR?
Loved this insightful conversation with patient advocates #RickBangs & @MargoWickersham at #IBCG2026 @IBCG_BladderCA
In the current therapeutic era, we need to rethink the terms we use & redefine success beyond scans; to include living well, QOL & what matters most to patients to work towards helping them achieve their overall goals.
Because the goal is not just surviving with cancer, but thriving.
@UroDocAsh @spsutkaMD @UrogerliMD @BladderCancerUS @WorldBladderCan @montypal @PGrivasMDPhD @crisbergerot @ASCO
@AmerUrological @Uroweb @DrYukselUrun @CleClinicMD @Uromigos @OncBrothers @fumikochino @minasedrakmd
Full discussion here 🎥 bit.ly/4hKmcfH
Patient perspectives on the meaning of response after systemic therapy for #BladderCancer.
What does "response" mean to a patient? #BladderCancer advocates Rick Bangs @BladderCancerUS and @MargoWickersham join @shilpaonc @ClevelandClinic to discuss how bladder cancer patients interpret treatment response terminology at #IBCG2026, noting that patients often hear "complete response" as cancer gone for good, not a snapshot requiring ongoing discussion. #WatchNow > bit.ly/4hKmcfH #IBCG26 @IBCG_BladderCA @UroDocAsh
Bladder Cancer Advocacy Network retweeted
This is Mary Dunn, one of the doctors that introduced me to the new BCG pain mgmt protocol I'm using. It really helps! Thank you to @BladderCancerUS & the Bladder Cancer Matters podcast for elevating this conversation! If you'd like more info, send me a DM #BladderCancer #BCG
REMINDER: Applications for BCAN’s 2026 Career Development Award close 10/26 at 5 p.m. ET.
The three-year, $250,000 grant supports early-career faculty establishing independent bladder cancer research programs.
Congratulations on your final show @chrisparente! We're sorry it took bladder cancer to bring us together but glad to have you as part of the BCAN family.
Before his final show on Oct. 12, the always-cheerful Chris Parente spoke about a career on Denver airwaves, his fight against bladder cancer and what he's up to next: westword.com/news/longtime-d…
Bladder Cancer Advocacy Network retweeted
Cancer Taught Me This: Live with the Question Mark ❤️💪💯 #suddenurgency youtube.com/shorts/J8TeBIKqJ… via @YouTube
Congrats to @angiesmith_uro and @FlorianSchroeck for receiving @theNCI funding for your R01, “Effectiveness of Medical and Environmental Interventions to Reduce Cystoscopy.” We appreciate your commitment to a patient-generated idea!
Bladder Cancer Advocacy Network retweeted
Treatment Burden in Cancer: Exploring the Unsung Work of Patients and Survivors
📅 October 8th, 11 a.m.-12 p.m. ET
Discuss the growing field of cancer-related treatment burden, strategies to measure and address it, and future research priorities.
Register: go.nih.gov/zZVsflL
We are pleased to introduce our October Partner in Progress: EMD Serono. Learn more about their treatments for bladder cancer: bcan.pulse.ly/msg1ewameh
Bladder Cancer Advocacy Network retweeted
1 Year With Cancer -- 10 Lessons Learned youtu.be/BXDNyorRaqE?is=RYQO… via @YouTube
Sexual health belongs in bladder cancer care. On Bladder Cancer Matters, nurse practitioner @MaryWDunn
joins Rick Bangs to discuss intimacy and treatment-related changes. Share with your patients to help them feel comfortable starting the conversation.
Thank you for having these conversations and letting know it's ok for patients to bring up the topic of sexual health.
What you don't ask, you don't know.
Sexual health is still overlooked in women with bladder cancer. Colleagues, what's the biggest barrier to raising it in your clinic?
#BladderCancer #UroSoMe @AmerUrological @BladderCancerUS @IBCG_BladderCA @UroOnc @WUO_SUO @SWIUorg
“Analyzing RNA can tell us not only whether a cancer is present — but also what it’s doing.” -- @max_diehn Great summary of the study published in @NatureMedicine
Stanford Medicine researchers developed a urine test that detects bladder cancer, predicts which patients will benefit from immunotherapy versus chemotherapy, and can confirm whether treatment worked.
med.stanford.edu/news/all-ne…
Bladder Cancer Advocacy Network retweeted
More than a diagnosis: Global survey exposes the emotional and physical toll of #BladderCancer treatment. Gina Carithers @PCFnews joins @UroDocAsh @UTMDAnderson reflecting on the Bladder Burden Survey, which included responses from more than 800 patients and 800 urologists, and emphasized that many patients hesitate to share how bladder cancer affects daily life because they do not want to burden their doctors. She encourages clinicians to treat each visit as a personal conversation and highlights @BladderCancerUS and the @WorldBladderCan as key organizations expanding patient resources across languages and cultures. #WatchNow >
bit.ly/4fvAZKz


















